In addition, a series of studies have also demonstrated that PD-L1 and PD-1 are widely expressed in CC tumor cells and stroma, indicating potential therapeutic targets of PD-1/PD-L1 inhibitors (20–22). This evidence concerns the gene CD274 and cholangiocarcinoma.